Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AQX-016A is an orally active and potent SHIP1 agonist. AQX-016A is a structural analog of pelorol which is 3 times more potent than the marine natural product pelorol at the same molar concentration. AQX-016A can activate recombinant SHIP1 enzyme in vitro and stimulate SHIP1 activity. AQX-016A also can inhibit the PI3K pathway and TNFa production, can be useful for various inflammatory diseases research [1] [2].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 491,500 |
50 mg | 約6-8 週間 | ¥ 639,500 |
100 mg | 約6-8 週間 | ¥ 808,000 |
説明 | AQX-016A is an orally active and potent SHIP1 agonist. AQX-016A is a structural analog of pelorol which is 3 times more potent than the marine natural product pelorol at the same molar concentration. AQX-016A can activate recombinant SHIP1 enzyme in vitro and stimulate SHIP1 activity. AQX-016A also can inhibit the PI3K pathway and TNFa production, can be useful for various inflammatory diseases research [1] [2]. |
In vitro | AQX-016A, across various concentrations and durations (0-15 μM, 0-90 min), demonstrably modulates immune response and signaling pathways through specific inhibition and activation mechanisms. At 5 μg/mL for 30 minutes, it suppresses the PI3K-mediated rise in intracellular PIP3 by activating a 5' phosphatase enzyme, leading to decreased PIP3 levels [1]. Furthermore, it effectively blocks LPS-induced PKB phosphorylation in a SHIP-dependent manner and significantly curtails TNFα production in J774 and peritoneal macrophages, as well as in BMDM, particularly requiring SHIP for maximum reduction of TNFα and selectively targeting TNF production from SHIP1 +/+ macrophages over SHIP1 -/- ones [1]. Additionally, AQX-016A inhibits TNFα translation and, at increased concentrations, enhances SHIP1 enzyme activity, both in vitro and in intact cells, consequently inhibiting activation of macrophages and mast cells [2]. In a dose-dependent manner, it preferentially prevents LPS-stimulated PKB phosphorylation and inhibits the phosphorylation of PKB, p38 MAPK, and ERK in SHIP1 +/+ mast cells, showcasing its specificity for SHIP-expressing hematopoietic cells, and highlights its potential in targeting PI3K-dependent responses in immune cells in a SHIP-dependent manner [2]. |
In vivo | AQX-016A, administered orally at a dose of 20 mg/kg once, significantly lowers plasma TNFa levels and reduces inflammation in a mouse model of endotoxemia [1] [2]. |
分子量 | 328.49 |
分子式 | C22H32O2 |
CAS No. | 849669-54-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AQX-016A 849669-54-1 AQX016A AQX 016A Inhibitor inhibitor inhibit